# Molecular Imaging of Inflammation in Parkinson's Disease Using LPS and TSPO-PET/MR

> **NCT05205291** · — · RECRUITING · sponsor: **University of Exeter** · enrollment: 30 (estimated)

## Conditions studied

- Neurodegenerative Diseases
- Parkinson Disease
- REM Sleep Behavior Disorder (iRBD)

## Interventions

- **DRUG:** Lipopolysaccharide
- **RADIATION:** PET/MR with [11C]PBR28

## Key facts

- **NCT ID:** NCT05205291
- **Lead sponsor:** University of Exeter
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-02-28
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05205291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05205291, "Molecular Imaging of Inflammation in Parkinson's Disease Using LPS and TSPO-PET/MR". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05205291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*